Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 8/20 | 0.64 |
| ▸ | CNR1 | P21554 | 3/20 | 0.64 |
| ▸ | LDHA | P00338 | 1/20 | 0.64 |
| ▸ | PPARG | P37231 | 1/20 | 0.64 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.64 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28836909 | 0.93 | CNR2 (0.55) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL18213631 | 0.84 | CNR2 (0.46) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL20383916 | 0.84 | CNR1 (0.63) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL23873911 | 0.80 | CNR2 (0.52) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL25072245 | 0.80 | CNR2 (0.52) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL13214133 | 0.80 | CNR1 (0.68) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL29691660 | 0.80 | CNR1 (0.68) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL16769849 | 0.80 | CNR1 (0.68) | CNR2CNR1LDHAPPARGTRPM8 | |
| SCHEMBL18909013 | 0.80 | CNR1 (0.68) | CNR2CNR1LDHAPPARGTRPM8 | |
| Delta9-Tetrahydrocannabinolic Acid A SCHEMBL23076463 | 0.78 | CNR2 (1.00) | CNR2CNR1LDHAPPARGTRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230135108-A1 | CANNABINOID SALT COMPOUNDS AND METHODS OF MAKING SAME | CANOPY GROWTH CORPORATION (CA) | 2023-05-04 | — | — | US | disclosed |
| US-20230135108-A1 | CANNABINOID SALT COMPOUNDS AND METHODS OF MAKING SAME | CANOPY GROWTH CORPORATION (CA) | 2023-05-04 | — | — | US | disclosed |
| CN-113543865-A | Extraction method and composition obtained by the extraction method | 天然成分有限责任公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-112638851-A | Process for the gas phase decarboxylation of cannabinoids | 自然萃取系统有限责任公司 | 2021-04-09 | — | — | CN | disclosed |
| EP-3291807-B1 | HYDROGENATION OF CANNABIS OIL | SCIALDONE MARK ANDREW (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20190030102-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2019-01-31 | — | — | US | disclosed |
| US-20170266245-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2017-09-21 | — | — | US | disclosed |
| US-20170266245-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2017-09-21 | — | — | US | disclosed |
| US-9694040-B2 | Hydrogenation of cannabis oil | RESEARCH GROW LABS | 2017-07-04 | — | — | US | disclosed |
| US-9694040-B2 | Hydrogenation of cannabis oil | RESEARCH GROW LABS | 2017-07-04 | — | — | US | disclosed |
| US-20160324909-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2016-11-10 | — | — | US | disclosed |
| US-20160324909-A1 | HYDROGENATION OF CANNABIS OIL | RESEARCH GROW LABS | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190030102-A1 | HYDROGENATION OF CANNABIS OIL | CNR2, CNR1, HHAT | CNR2 1/4885CNR1 2/4885LDHA 3657/4885 |
| US-20160324909-A1 | HYDROGENATION OF CANNABIS OIL | CNR2, CNR1, HHAT | CNR2 1/4885CNR1 2/4885LDHA 3657/4885 |
| US-20230135108-A1 | CANNABINOID SALT COMPOUNDS AND METHODS OF MAKING SAME | CNR1, CNR2, CDIPT | CNR2 2/4885CNR1 1/4885LDHA 4735/4885 |
| US-20170266245-A1 | HYDROGENATION OF CANNABIS OIL | CNR2, CNR1, HHAT | CNR2 1/4885CNR1 2/4885LDHA 3657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.